{
  "id": 18500907,
  "title": "Commensal Engineered Living Materials for Sustained Secretome Delivery and Wound Healing",
  "url": "https://urgent.news/2026/11/06/commensal-engineered-living-materials-for-sustained-secretome",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-06T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.04.764344v1?rss=1"
  },
  "original_language": "en",
  "account": "A new technique has been developed to harness living cells as biological factories for producing therapeutic proteins in compromised tissues. This approach holds particular promise for treating chronic non-healing wounds, which struggle with ineffective therapeutic options within their inflammatory surroundings. While commensal bacteria can indeed aid healing in such hostile environments, directly applying live microbes to damaged tissue poses significant clinical challenges due to safety and engraftment issues.\n\nTo address these concerns, researchers have created a well-defined commensal Engineered Living Material (cELM). This material enables the encapsulation, retention, functioning, and delivery of native beneficial bacteria to provide localized production and release of a pro-healing secretome over extended periods. Specifically, the researchers encapsulated a pro-healing human wound bacterial isolate called Alcaligenes faecalis using biocompatible, click-reactive hydrogel building blocks. By varying the density of the polymer network and the encapsulated bacteria, they established design rules for creating effective pro-healing cELMs.\n\nThe hydrogel network ensured bacterial biocontainment while still allowing therapeutic secretome to diffuse through the mesh size. Interestingly, the study found an inverse relationship between encapsulation density and per-cell metabolic activity; lower cell densities resulted in significantly enhanced production of pro-healing secreted factors. In a murine diabetic wound model, these A. faecalis cELMs successfully shielded the encapsulated bacteria from host clearance, maintained biocontainment, accelerated re-epithelialization, and improved wound bed maturity.\n\nThese findings provide design principles for cELMs that effectively couple bacterial biocontainment with sustained secretome delivery. This innovative approach offers a promising platform for targeted treatment of chronic wounds, addressing the limitations of current therapeutic options.",
  "summary": "Using living cells as dynamic biological factories offers immense potential for the continuous, localized production of therapeutic proteins within compromised tissues. This strategy is particularly compelling for treating chronic non-healing wounds, which lack therapeutics that are able to function effectively in the inflammatory microenvironment. Commensal bacteria have been shown to promote…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}